BREAKING
Importance
82
Trust
76
Urgency
95
APPROVAL✓ 3 outlets
Orbicular Announces Health Canada Approval for a g-Ozempic (Semaglutide Injection) in Partnership with Apotex - ANI News
Orbicular and Apotex won approval from Health Canada to sell a generic copy of semaglutide injection (the active ingredient in Ozempic). This is a cheaper version of the weight-loss and diabetes drug.
Analysis
A generic version of Ozempic just got the green light in Canada. That could push prices down and take sales away from Novo Nordisk.
- Health Canada approved a generic semaglutide injection
- Orbicular partnered with Apotex on the product
- Generic copies the active ingredient in Ozempic
Semaglutide News1mo
Read